Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:07
10/07/22
10/07
11:07
10/07/22
11:07
MRSN

Mersana Therapeutics

$7.51 /

-0.02 (-0.27%)

, BHVN

Biohaven Pharmaceutical

$13.08 /

-0.16 (-1.21%)

, TCON

Tracon Pharmaceuticals

$1.75 /

-0.02 (-1.13%)

, SLRX

Salarius Pharmaceuticals

/

+

These names in the…

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$1.75 /

-0.02 (-1.13%)

SLRX Salarius Pharmaceuticals
/

+

MRSN Mersana Therapeutics
$7.51 /

-0.02 (-0.27%)

BHVN Biohaven Pharmaceutical
$13.08 /

-0.16 (-1.21%)

MRSN Mersana Therapeutics
$7.51 /

-0.02 (-0.27%)

08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
05/10/22 Baird
Mersana Therapeutics price target lowered to $18 from $23 at Baird
05/09/22 H.C. Wainwright
Mersana price target lowered to $19 from $24 at H.C. Wainwright
11/10/21 Baird
Mersana Therapeutics price target lowered to $23 from $30 at Baird
BHVN Biohaven Pharmaceutical
$13.08 /

-0.16 (-1.21%)

08/18/22 Piper Sandler
Biohaven downgraded to Neutral from Overweight at Piper Sandler
08/08/22 Wedbush
Wedbush downgrades Biohaven to Neutral, sees Pfizer acquisition on track
08/08/22 Wedbush
Biohaven Pharmaceutical downgraded to Neutral from Outperform at Wedbush
05/23/22 Piper Sandler
Biohaven price target lowered to $149 from $170 at Piper Sandler
TCON Tracon Pharmaceuticals
$1.75 /

-0.02 (-1.13%)

02/23/22 Baird
Baird starts Tracon at Outperform, sees 70% odds of success for envafolimab
02/22/22 Baird
Tracon Pharmaceuticals initiated with an Outperform at Baird
12/27/21 Alliance Global Partners
Alliance Global says Tracon's higher dosing 'logical,' though will delay results
12/27/21 H.C. Wainwright
H.C. Wainwright reaffirms Buy on Tracon after IDMC recommends trial continue
SLRX Salarius Pharmaceuticals
/

+

03/11/22 H.C. Wainwright
Salarius Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright
01/13/22 H.C. Wainwright
Salarius' pipeline has grown in diversification after deal, says H.C. Wainwright
12/29/21 H.C. Wainwright
H.C. Wainwright reiterates Buy on Salarius after dosing milestone reached
TCON Tracon Pharmaceuticals
$1.75 /

-0.02 (-1.13%)

SLRX Salarius Pharmaceuticals
/

+

MRSN Mersana Therapeutics
$7.51 /

-0.02 (-0.27%)

BHVN Biohaven Pharmaceutical
$13.08 /

-0.16 (-1.21%)

  • 19
    Jul
MRSN Mersana Therapeutics
$7.51 /

-0.02 (-0.27%)

BHVN Biohaven Pharmaceutical
$13.08 /

-0.16 (-1.21%)

Yesterday
Hot Stocks
Mersana Therapeutics completes patient enrollment in UPLIFT trial » 16:11
10/06/22
10/06
16:11
10/06/22
16:11
MRSN

Mersana Therapeutics

$7.48 /

-0.28 (-3.61%)

Mersana Therapeutics…

Mersana Therapeutics announced the completion of patient enrollment in UPLIFT, the company's single-arm registrational trial of UpRi in platinum-resistant ovarian cancer. UpRi is Mersana's first-in-class NaPi2b-targeting ADC with a novel scaffold-linker-payload that enables a high drug-to-antibody ratio and controlled bystander effect.

ShowHide Related Items >><<
MRSN Mersana Therapeutics
$7.48 /

-0.28 (-3.61%)

MRSN Mersana Therapeutics
$7.48 /

-0.28 (-3.61%)

08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
05/10/22 Baird
Mersana Therapeutics price target lowered to $18 from $23 at Baird
05/09/22 H.C. Wainwright
Mersana price target lowered to $19 from $24 at H.C. Wainwright
11/10/21 Baird
Mersana Therapeutics price target lowered to $23 from $30 at Baird
MRSN Mersana Therapeutics
$7.48 /

-0.28 (-3.61%)

MRSN Mersana Therapeutics
$7.48 /

-0.28 (-3.61%)

Recommendations
Trex Company price target lowered to $65 from $85 at Truist » 09:19
10/06/22
10/06
09:19
10/06/22
09:19
TREX

Trex Company

$48.46 /

-0.72 (-1.46%)

Truist analyst Keith…

Truist analyst Keith Hughes lowered the firm's price target on Trex Company to $65 from $85 and keeps a Buy rating on the shares. The analyst is raising his FY22 EPS view to $1.92 from $1.82 as he sees less than expected weakening of sell through relative to the Trex management's "very bearish" guidance in early August, though he continues to see a "downturn year" in 2023 for the sector.

ShowHide Related Items >><<
TREX Trex Company
$48.46 /

-0.72 (-1.46%)

TREX Trex Company
$48.46 /

-0.72 (-1.46%)

08/17/22 Deutsche Bank
Armstrong World, Trex among Deutsche Bank's top building products picks
08/17/22 Deutsche Bank
Trex Company initiated with a Buy at Deutsche Bank
08/09/22 DA Davidson
Trex Company price target lowered to $58 from $67 at DA Davidson
08/09/22 B. Riley
Trex Company should be bought on earnings selloff, says B. Riley
TREX Trex Company
$48.46 /

-0.72 (-1.46%)

TREX Trex Company
$48.46 /

-0.72 (-1.46%)

Options
Largest borrow rate increases among liquid names » 08:45
10/06/22
10/06
08:45
10/06/22
08:45
LABD

Daily S&P Biotech Bear 3x Shares

$20.98 /

+0.22 (+1.06%)

, TTCF

Tattooed Chef

$5.09 /

-0.2 (-3.78%)

, MAXN

Maxeon Solar

$24.64 /

-0.99 (-3.86%)

, NEGG

Newegg Commerce

$2.42 /

+0.015 (+0.63%)

, NVAX

Novavax

$18.69 /

-0.71 (-3.66%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: (LABD) 18.39% +2.15, Direxion S&P Biotech Bear 3X (LABD) 18.39% +2.15, Tattooed Chef (TTCF) 17.91% +0.60, (TTCF) 17.91% +0.60, Maxeon Solar Technologies (MAXN) 3.71% +0.35, (MAXN) 3.71% +0.35, (NEGG) 50.90% +0.34, Newegg Commerce (NEGG) 50.90% +0.34, Novavax (NVAX) 1.10% +0.24, and (NVAX) 1.10% +0.24.

ShowHide Related Items >><<
TTCF Tattooed Chef
$5.09 /

-0.2 (-3.78%)

NVAX Novavax
$18.69 /

-0.71 (-3.66%)

NEGG Newegg Commerce
$2.42 /

+0.015 (+0.63%)

MAXN Maxeon Solar
$24.64 /

-0.99 (-3.86%)

LABD Daily S&P Biotech Bear 3x Shares
$20.98 /

+0.22 (+1.06%)

LABD Daily S&P Biotech Bear 3x Shares
$20.98 /

+0.22 (+1.06%)

TTCF Tattooed Chef
$5.09 /

-0.2 (-3.78%)

09/30/22 UBS
Tattooed Chef initiated with a Neutral at UBS
08/15/22 Cowen
Tattooed Chef price target lowered to $10 from $13
08/09/22 Roth Capital
Roth Capital downgrades Tattooed Chef to Neutral, lowers price target to $9
08/09/22 Roth Capital
Tattooed Chef downgraded to Neutral from Buy at Roth Capital
MAXN Maxeon Solar
$24.64 /

-0.99 (-3.86%)

09/18/22 BofA
Maxeon Solar price target raised to $30 from $25 at BofA
09/07/22 Goldman Sachs
Maxeon Solar upgraded to Buy from Sell at Goldman Sachs
08/18/22 Morgan Stanley
Maxeon Solar price target raised to $21 from $14 at Morgan Stanley
08/16/22 Raymond James
Maxeon Solar downgraded to Market Perform from Outperform at Raymond James
NEGG Newegg Commerce
$2.42 /

+0.015 (+0.63%)

NVAX Novavax
$18.69 /

-0.71 (-3.66%)

09/22/22 JPMorgan
Novavax downgraded to Underweight from Neutral at JPMorgan
08/10/22 B. Riley
Novavax price target lowered to $126 from $171 at B. Riley
08/09/22 Cowen
Novavax price target lowered to $110 from $150 at Cowen
07/22/22 B. Riley
Novavax price target lowered to $171 from $181 at B. Riley
TTCF Tattooed Chef
$5.09 /

-0.2 (-3.78%)

NVAX Novavax
$18.69 /

-0.71 (-3.66%)

NEGG Newegg Commerce
$2.42 /

+0.015 (+0.63%)

MAXN Maxeon Solar
$24.64 /

-0.99 (-3.86%)

NVAX Novavax
$18.69 /

-0.71 (-3.66%)

MAXN Maxeon Solar
$24.64 /

-0.99 (-3.86%)

TTCF Tattooed Chef
$5.09 /

-0.2 (-3.78%)

NVAX Novavax
$18.69 /

-0.71 (-3.66%)

NEGG Newegg Commerce
$2.42 /

+0.015 (+0.63%)

MAXN Maxeon Solar
$24.64 /

-0.99 (-3.86%)

TTCF Tattooed Chef
$5.09 /

-0.2 (-3.78%)

NVAX Novavax
$18.69 /

-0.71 (-3.66%)

NEGG Newegg Commerce
$2.42 /

+0.015 (+0.63%)

MAXN Maxeon Solar
$24.64 /

-0.99 (-3.86%)

LABD Daily S&P Biotech Bear 3x Shares
$20.98 /

+0.22 (+1.06%)

Recommendations
CarGurus price target lowered to $20 from $32 at Jefferies » 08:01
10/06/22
10/06
08:01
10/06/22
08:01
CARG

CarGurus

$14.61 /

-0.61 (-4.01%)

Jefferies analyst John…

Jefferies analyst John Colantuoni lowered the firm's price target on CarGurus to $20 from $32 and keeps a Buy rating on the shares. The analyst reduced estimates and price targets across U.S. internet in anticipation of a slowing macro environment. He thinks share multiples are likely to inflect before fundamentals, and recommends "leaning on" risk/reward to determine which Internet stocks to own long term. His preference is to hold names offering a combination of "competitive differentiation, exposure to attractive end-markets, levers to offset softer demand, and robust" free cash flow. Colantuoni reduced 2023 revenue estimates by 5% on average, which results in his numbers falling 4% below consensus. However, the correction across internet has created more attractive risk/rewards, the analyst writes. He believes Airbnb (ABNB) offers the most recession-proof characteristics, ACV Auctions (ACV) offers the most attractive long-term growth profile, and Etsy (ETSY) offers fundamentals that have already "hit trough."

ShowHide Related Items >><<
CARG CarGurus
$14.61 /

-0.61 (-4.01%)

CARG CarGurus
$14.61 /

-0.61 (-4.01%)

09/30/22 Raymond James
CarGurus price target lowered to $20 from $28 at Raymond James
09/20/22 BTIG
CarGurus price target lowered to $25 from $30 at BTIG
09/20/22 Needham
CarGurus price target lowered to $21 from $27 at Needham
09/09/22 Oppenheimer
CarGurus price target lowered to $23 from $32 at Oppenheimer
CARG CarGurus
$14.61 /

-0.61 (-4.01%)

CARG CarGurus
$14.61 /

-0.61 (-4.01%)

CARG CarGurus
$14.61 /

-0.61 (-4.01%)

Wednesday
Hot Stocks
North American rail traffic down 1.1% for the week ending October 1 » 13:37
10/05/22
10/05
13:37
10/05/22
13:37
CNI

Canadian National

$114.15 /

-1.57 (-1.36%)

, CP

Canadian Pacific

$71.33 /

-1.09 (-1.51%)

, CSX

CSX

$27.98 /

-0.13 (-0.46%)

, KSU

Kansas City Southern

$293.64 /

+ (+0.00%)

, NSC

Norfolk Southern

$222.46 /

-0.72 (-0.32%)

, UNP

Union Pacific

$202.00 /

-3.23 (-1.57%)

, RAIL

FreightCar America

$3.99 /

-0.05 (-1.24%)

, TRN

Trinity Industries

$23.54 /

+0.035 (+0.15%)

, GBX

Greenbrier

$26.70 /

+0.37 (+1.41%)

, WAB

Wabtec

$88.50 /

+0.35 (+0.40%)

The Association of…

The Association of American Railroads or AAR, reported U.S. rail traffic for the week ending October 1, as well as volumes for September . U.S. railroads originated 928,590 carloads in September, down 1.1%, or 10,639 carloads, from September 2021. U.S. railroads also originated 1,011,304 containers and trailers in September 2022, down 4.8%, or 51,039 units, from the same month last year. Combined U.S. carload and intermodal originations in September were 1,939,894, down 3.1%, or 61,678 carloads and intermodal units from September 2021. In September, six of the 20 carload commodity categories tracked by the AAR each month saw carload gains compared with September 2021. These included: crushed stone, sand & gravel, up 8,987 carloads or 11.2%; motor vehicles & parts, up 8,380 carloads or 18%; and coal, up 4,886 carloads or 1.8%. Commodities that saw declines in September 2022 from September 2021 included: primary metal products, down 6,341 carloads or 16.6%; all other carloads, down 4,879 carloads or 21%; and grain, down 4,227 carloads or 5%. North American rail volume for the week ending October 1, on 12 reporting U.S., Canadian and Mexican railroads totaled 337,140 carloads, down 0.8 percent compared with the same week last year, and 350,834 intermodal units, down 1.3% compared with last year. Total combined weekly rail traffic in North America was 687,974 carloads and intermodal units, down 1.1%. North American rail volume for the first 39 weeks of 2022 was 26,388,292 carloads and intermodal units, down 2.3 percent compared with 2021. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), FreightCar America (RAIL), Trinity Industries (TRN), Greenbrier (GBX) and Wabtec (WAB). Reference Link

ShowHide Related Items >><<
WAB Wabtec
$88.50 /

+0.35 (+0.40%)

TRN Trinity Industries
$23.54 /

+0.035 (+0.15%)

RAIL FreightCar America
$3.99 /

-0.05 (-1.24%)

NSC Norfolk Southern
$222.46 /

-0.72 (-0.32%)

CNI Canadian National
$114.15 /

-1.57 (-1.36%)

CNI Canadian National
$114.15 /

-1.57 (-1.36%)

09/30/22 Barclays
Canadian National price target lowered to $110 from $115 at Barclays
09/28/22 Susquehanna
Canadian National price target lowered to $109 from $129 at Susquehanna
09/22/22 National Bank
Canadian National price target raised to C$173 from C$166 at National Bank
09/12/22 BofA
Trio of railroad operators upgraded to Buy at BofA as volume turns around
CP Canadian Pacific
$71.33 /

-1.09 (-1.51%)

09/30/22 Barclays
Canadian Pacific price target lowered to $77 from $88 at Barclays
09/29/22 Citi
Canadian Pacific price target lowered to $79 from $81 at Citi
09/28/22 Susquehanna
Canadian Pacific price target lowered to $79 from $84 at Susquehanna
09/22/22 National Bank
Canadian Pacific price target raised to C$105 from C$98 at National Bank
CSX CSX
$27.98 /

-0.13 (-0.46%)

09/30/22 Barclays
CSX price target lowered to $35 from $40 at Barclays
09/29/22 Citi
CSX price target lowered to $30 from $31 at Citi
09/28/22 Susquehanna
Susquehanna cautious on rails into 2023, downgrades CSX
09/28/22 Susquehanna
CSX downgraded to Neutral from Positive at Susquehanna
KSU Kansas City Southern
$293.64 /

+ (+0.00%)

06/27/22 Credit Suisse
Canadian National initiated with a Neutral at Credit Suisse
03/10/22 JPMorgan
JPMorgan resumes Canadian Pacific at Overweight, adds to Focus List
12/20/21 Evercore ISI
Canadian Pacific resumed at Outperform from In Line at Evercore ISI
11/29/21 Deutsche Bank
Canadian Pacific downgraded to Hold on new debt at Deutsche Bank
NSC Norfolk Southern
$222.46 /

-0.72 (-0.32%)

09/30/22 Barclays
Norfolk Southern price target lowered to $230 from $255 at Barclays
09/29/22 Citi
Norfolk Southern price target lowered to $225 from $245 at Citi
09/28/22 Susquehanna
Susquehanna cautious on rails into 2023, downgrades Norfolk Southern
09/28/22 Susquehanna
Norfolk Southern downgraded to Neutral from Positive at Susquehanna
UNP Union Pacific
$202.00 /

-3.23 (-1.57%)

09/30/22 Barclays
Union Pacific price target lowered to $235 from $255 at Barclays
09/29/22 Citi
Union Pacific price target lowered to $210 from $220 at Citi
09/28/22 Susquehanna
Union Pacific price target lowered to $208 from $240 at Susquehanna
09/14/22 Bernstein
Bernstein downgrades Union Pacific to Market Perform, cuts price target to $230
RAIL FreightCar America
$3.99 /

-0.05 (-1.24%)

TRN Trinity Industries
$23.54 /

+0.035 (+0.15%)

07/28/22 Wells Fargo
Trinity Industries price target lowered to $33 from $38 at Wells Fargo
GBX Greenbrier
$26.70 /

+0.37 (+1.41%)

07/13/22 Cowen
Greenbrier price target lowered to $47 from $54
07/12/22 Susquehanna
Greenbrier price target lowered to $38 from $58 at Susquehanna
07/11/22 BofA
Greenbrier downgraded to Neutral at BofA after Q3 earnings miss
07/11/22 BofA
Greenbrier downgraded to Neutral from Buy at BofA
WAB Wabtec
$88.50 /

+0.35 (+0.40%)

08/18/22 Raymond James
Wabtec initiated with an Outperform at Raymond James
06/23/22 Morgan Stanley
Wabtec downgraded to Equal Weight from Overweight at Morgan Stanley
05/23/22 Atlantic Equities
Wabtec initiated with Overweight, $101 target at Atlantic Equities
05/23/22 Atlantic Equities
Wabtec initiated with an Overweight at Atlantic Equities
WAB Wabtec
$88.50 /

+0.35 (+0.40%)

UNP Union Pacific
$202.00 /

-3.23 (-1.57%)

TRN Trinity Industries
$23.54 /

+0.035 (+0.15%)

RAIL FreightCar America
$3.99 /

-0.05 (-1.24%)

NSC Norfolk Southern
$222.46 /

-0.72 (-0.32%)

GBX Greenbrier
$26.70 /

+0.37 (+1.41%)

CSX CSX
$27.98 /

-0.13 (-0.46%)

CP Canadian Pacific
$71.33 /

-1.09 (-1.51%)

CNI Canadian National
$114.15 /

-1.57 (-1.36%)

CNI Canadian National
$114.15 /

-1.57 (-1.36%)

WAB Wabtec
$88.50 /

+0.35 (+0.40%)

UNP Union Pacific
$202.00 /

-3.23 (-1.57%)

RAIL FreightCar America
$3.99 /

-0.05 (-1.24%)

NSC Norfolk Southern
$222.46 /

-0.72 (-0.32%)

GBX Greenbrier
$26.70 /

+0.37 (+1.41%)

CSX CSX
$27.98 /

-0.13 (-0.46%)

CNI Canadian National
$114.15 /

-1.57 (-1.36%)

UNP Union Pacific
$202.00 /

-3.23 (-1.57%)

CSX CSX
$27.98 /

-0.13 (-0.46%)

Tuesday
Hot Stocks
TaskUs announces expansion to Navi Mumbai » 10:44
10/04/22
10/04
10:44
10/04/22
10:44
TASK

TaskUs

$17.66 /

+0.96 (+5.75%)

TaskUs announced Navi…

TaskUs announced Navi Mumbai as home to its fourth site in India. TaskUs Navi Mumbai will support the company's growing operations in India, which has been TaskUs' fastest-growing market in its 14-year history. The city has a highly skilled and tech-savvy talent pool, modern infrastructure, and a non-metro advantage. The expansion also aims to provide teammates with world-class, people-first facilities and a spacious workspace. As TaskUs' fourth site in India, Navi Mumbai sits on a mature social infrastructure populated with educational hubs, commercial spaces, retail complexes, and residential areas. With its close proximity to Mumbai, Pune, and Thane, the city boasts access to a large experienced talent pool that makes for a flexible, adept, and robust workforce.

ShowHide Related Items >><<
TASK TaskUs
$17.66 /

+0.96 (+5.75%)

TASK TaskUs
$17.66 /

+0.96 (+5.75%)

09/14/22 RBC Capital
TaskUs price target lowered to $26 from $36 at RBC Capital
08/15/22 Morgan Stanley
TaskUs downgraded to Equal Weight from Overweight at Morgan Stanley
08/15/22 Morgan Stanley
TaskUs downgraded to Equal Weight from Overweight at Morgan Stanley
08/09/22 Goldman Sachs
TaskUs downgraded to Neutral from Buy at Goldman Sachs
TASK TaskUs
$17.66 /

+0.96 (+5.75%)

  • 21
    Oct
TASK TaskUs
$17.66 /

+0.96 (+5.75%)

Hot Stocks
Qualys announces it acquired assets of Blue Hexagon » 09:17
10/04/22
10/04
09:17
10/04/22
09:17
QLYS

Qualys

$143.28 /

+3.43 (+2.45%)

Qualys announced it…

Qualys announced it acquired the assets of Blue Hexagon. This brings AI/machine learning to the Qualys Cloud Platform to help convert petabytes of highly integrated data into meaningful insights for customers. This acquisition will enable Qualys to leverage its powerful Cloud Platform and its more than 10 trillion data points to uncover behavior patterns including active vulnerability exploitation, identification of advanced network threats, and adaptive risk mitigation across all assets and applications. "It is a pleasure to welcome the brightest minds in AI/ML and cybersecurity to the Qualys team," said Sumedh Thakar, president and CEO of Qualys. "Qualys' mission is helping organizations identify and reduce cyber risks, and the blue hexagon platform will enable us to provide powerful context-aware insights that will enhance our customers' cyber resilience."

ShowHide Related Items >><<
QLYS Qualys
$143.28 /

+3.43 (+2.45%)

QLYS Qualys
$143.28 /

+3.43 (+2.45%)

08/09/22 Northland
Qualys price target raised to $142 from $138 at Northland
08/09/22 DA Davidson
Qualys price target raised to $135 from $120 at DA Davidson
08/09/22 Morgan Stanley
Qualys price target raised to $123 from $113 at Morgan Stanley
08/09/22 Wedbush
Qualys price target lowered to $150 from $160 at Wedbush
QLYS Qualys
$143.28 /

+3.43 (+2.45%)

QLYS Qualys
$143.28 /

+3.43 (+2.45%)

Hot Stocks
LivePerson appoints Zive as Chief Marketing Officer » 09:14
10/04/22
10/04
09:14
10/04/22
09:14
LPSN

LivePerson

$9.72 /

+0.305 (+3.24%)

LivePerson announced the…

LivePerson announced the appointment of Chief Marketing Officer Ruth Zive, who will be introduced to customers as the host of the company's next Executive Community event in San Francisco on October 20. Zive will oversee LivePerson's global marketing organization, including digital and demand generation, field marketing and sales development, vertical and product marketing, branding, and internal and external communications. Her priority is to grow scalable, measurable, and predictable world-class demand generation while driving operational rigor.

ShowHide Related Items >><<
LPSN LivePerson
$9.72 /

+0.305 (+3.24%)

LPSN LivePerson
$9.72 /

+0.305 (+3.24%)

09/23/22 Credit Suisse
LivePerson initiated with an Underperform at Credit Suisse
09/12/22 KeyBanc
LivePerson initiated with an Overweight at KeyBanc
08/10/22 Loop Capital
LivePerson downgraded to Hold at Loop Capital yesterday
08/09/22 B. Riley
LivePerson price target lowered to $17 from $19 at B. Riley
LPSN LivePerson
$9.72 /

+0.305 (+3.24%)

LPSN LivePerson
$9.72 /

+0.305 (+3.24%)

Recommendations
Trinseo price target lowered to $20 from $34 at Citi » 08:11
10/04/22
10/04
08:11
10/04/22
08:11
TSE

Trinseo

$19.50 /

+1.17 (+6.38%)

Citi analyst Eric Petrie…

Citi analyst Eric Petrie lowered the firm's price target on Trinseo to $20 from $34 and keeps a Neutral rating on the shares. The analyst does not anticipate chemicals to outperform at least until next spring, when the energy price scenario "could be more benign" after the winter and high inventories of plastics could have worked down due to lowering of operating rates. With rising rates across the globe, certain end markets like construction and housing are slowing down, while others like auto manufacturing and aerospace "now seem closer to a trough," Petrie tells investors in a research note. The analyst remains below the Street for earnings estimates in 2023 and believes consensus estimates need to come down further.

ShowHide Related Items >><<
TSE Trinseo
$19.50 /

+1.17 (+6.38%)

TSE Trinseo
$19.50 /

+1.17 (+6.38%)

09/27/22 Deutsche Bank
Trinseo price target lowered to $22 from $34 at Deutsche Bank
08/18/22 Morgan Stanley
Trinseo price target lowered to $33 from $47 at Morgan Stanley
08/11/22 Deutsche Bank
Trinseo downgraded to Hold from Buy at Deutsche Bank
08/11/22 Deutsche Bank
Trinseo downgraded to Hold from Buy at Deutsche Bank
TSE Trinseo
$19.50 /

+1.17 (+6.38%)

TSE Trinseo
$19.50 /

+1.17 (+6.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.